Nipro and its affiliates are mainly engaged in the manufacture and sale of medical products and glass products. Co. operates in four business segments: medical-related, pharmaceutical-related, pharma packaging and others. Co.'s principal products include injection and infusion-related products, artificial organ-related products, highly functional products, dialysis-related products and diabetic-related products; injectable drug and oral drugs; and glass for glass tube, ampoule, syrings and cartridges. In addition, Co. is engaged in the manufacture and sale of medical products manufacturing machines, the real estate leasing and the non-life insurance agency business.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.